We are live on ! Find out more
TL

Tirschwell & Loewy Portfolio holdings

AUM $731M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
+10.6%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
–
AUM
$618M
AUM Growth
+$59.2M
Cap. Flow
+$4.22M
Cap. Flow %
0.68%
Top 10 Hldgs %
40.81%
Holding
81
New
1
Increased
26
Reduced
35
Closed
5

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$8.36M
2
BIVV
Bioverativ Inc. Common Stock
BIVV
+$1.83M
3
XRAY icon
Dentsply Sirona
XRAY
+$1M
4
MA icon
Mastercard
MA
+$824K
5
WSM icon
Williams-Sonoma
WSM
+$585K

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$4.88M
2
SO icon
Southern Company
SO
+$2.57M
3
FTV icon
Fortive
FTV
+$1.61M
4
CGNX icon
Cognex
CGNX
+$1.34M
5
KO icon
Coca-Cola
KO
+$814K

Sector Composition

Rank Sector Weight
1 Healthcare 41.03%
2 Technology 12.51%
3 Industrials 11.73%
4 Consumer Staples 7.1%
5 Consumer Discretionary 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGNX icon
1
Cognex
CGNX
$10.5B
$35.9M 5.81%
855,480
-36,640
-4% -$1.34M
TIF
2
DELISTED
Tiffany & Co.
TIF
$33.8M 5.48%
354,996
-1,600
-0.4% -$137K
ADI icon
3
Analog Devices
ADI
$181B
$26.2M 4.24%
319,581
-370
-0.1% -$29.1K
JNJ icon
4
Johnson & Johnson
JNJ
$599B
$25M 4.05%
200,906
-760
-0.4% -$90.8K
IDXX icon
5
Idexx Laboratories
IDXX
$44.5B
$25M 4.05%
161,735
-4,205
-3% -$580K
NEOG icon
6
Neogen
NEOG
$2.18B
$22.5M 3.64%
913,957
-4,147
-0.5% -$102K
DXCM icon
7
DexCom
DXCM
$29.2B
$22.2M 3.59%
1,046,680
-2,400
-0.2% -$46.8K
BIIB icon
8
Biogen
BIIB
$29.5B
$20.9M 3.39%
76,580
-675
-0.9% -$191K
DHR icon
9
Danaher
DHR
$142B
$20.3M 3.29%
267,935
+468
+0.2% +$34.8K
RTN
10
DELISTED
Raytheon Company
RTN
$20.3M 3.29%
133,192
+295
+0.2% +$44.4K
BF.B icon
11
Brown-Forman Class B
BF.B
$12.1B
$20M 3.23%
675,061
-12,350
-2% -$367K
HON icon
12
Honeywell
HON
$71.7B
$19.9M 3.23%
176,701
-996
-0.6% -$110K
MA icon
13
Mastercard
MA
$484B
$17.3M 2.8%
153,670
+7,515
+5% +$824K
HSIC icon
14
Henry Schein
HSIC
$9.82B
$16.8M 2.72%
252,039
+3,302
+1% +$215K
SLB icon
15
SLB Ltd
SLB
$69.4B
$14.1M 2.28%
180,177
-855
-0.5% -$69.9K
NVO
16
Novo Nordisk
NVO
$219B
$13.9M 2.25%
812,390
+11,600
+1% +$202K
AMGN icon
17
Amgen
AMGN
$197B
$13.6M 2.19%
82,597
+165
+0.2% +$27.4K
PODD icon
18
Insulet
PODD
$11.6B
$13M 2.1%
301,555
+830
+0.3% +$35.6K
INGN icon
19
Inogen
INGN
$173M
$12.8M 2.08%
165,565
+365
+0.2% +$25.3K
GWW icon
20
W.W. Grainger
GWW
$64.7B
$12.7M 2.05%
54,372
-1,205
-2% -$297K
SBUX icon
21
Starbucks
SBUX
$119B
$12.4M 2%
211,605
+147,755
+231% +$8.36M
XRAY icon
22
Dentsply Sirona
XRAY
$2.7B
$11.7M 1.89%
187,111
+16,636
+10% +$1M
ROST icon
23
Ross Stores
ROST
$75.6B
$11.1M 1.8%
168,835
+1,075
+0.6% +$71.8K
MTD icon
24
Mettler-Toledo International
MTD
$25.7B
$10.1M 1.64%
21,145
+35
+0.2% +$16K
ABMD
25
DELISTED
Abiomed Inc
ABMD
$10.1M 1.64%
80,705
+290
+0.4% +$33.6K
1
2 3 4

Similar funds

IAS
INR Advisory Services Media, Pennsylvania $786M AUM 2.23% 1-Year Est. Return
ACM
Aviance Capital Management Sarasota, Florida $668M AUM 6.48% 1-Year Est. Return
MFBTD
MB Financial Bank - Trust Department Rosemont, Illinois $816M AUM 5.49% 1-Year Est. Return
SGAM
Steinberg Global Asset Management Boca Raton, Florida $639M AUM 11.04% 1-Year Est. Return
AB
AT Bancorp Dubuque, Iowa $823M AUM 0.35% 1-Year Est. Return
NTC
NF Trinity Capital Central, Hong Kong $626M AUM 3.16% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
DSI
Daiwa SB Investments Tokyo, Japan $506M AUM 11% 1-Year Est. Return

Tirschwell & Loewy's Q1 2017 Portfolio in Review

As of Q1 2017, Tirschwell & Loewy held 81 positions worth $618M, up 11% from $559M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Tirschwell & Loewy's Q1 2017 filing shows 1 new, 26 increased, 35 reduced and 5 closed positions. Its largest new stake was Bioverativ Inc. Common Stock: 37,205 shares worth $2.03M. The largest sale was Wells Fargo, an estimated $4.88M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 40% a quarter earlier, followed by Technology and Industrials.

  • Tirschwell & Loewy's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 37,205 shares worth $2.03M.
  • Tirschwell & Loewy added most to Starbucks in Q1 2017, an estimated $8.36M increase.
  • Tirschwell & Loewy's biggest Q1 2017 reduction was Wells Fargo, cutting an estimated $4.88M.
  • Tirschwell & Loewy fully exited Southern Company in Q1 2017, selling an estimated $2.57M.
  • Tirschwell & Loewy's ten largest holdings make up 41% of its $618M portfolio in Q1 2017.
  • Tirschwell & Loewy opened 1 new position and closed 5 in Q1 2017.
  • Tirschwell & Loewy's portfolio value rose 11% quarter-over-quarter to $618M.

Based on Tirschwell & Loewy's 13F filing for Q1 2017, filed 4 May 2017.